Renner, C., Zinzani, P. L., Gressin, R., Klingbiel, D., Dietrich, P., Hitz, F., . . . Ketterer, N. (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Ferrata Storti Foundation.
Styl cytowania ChicagoRenner, Christoph, et al. A Multicenter Phase II Trial (SAKK 36/06) of Single-agent Everolimus (RAD001) in Patients With Relapsed or Refractory Mantle Cell Lymphoma. Ferrata Storti Foundation, 2012.
Styl cytowania MLARenner, Christoph, et al. A Multicenter Phase II Trial (SAKK 36/06) of Single-agent Everolimus (RAD001) in Patients With Relapsed or Refractory Mantle Cell Lymphoma. Ferrata Storti Foundation, 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..